Role of plasma exchange in ANCA-associated vasculitis

Abstract

The treatment for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has evolved over time, and people with these diseases now have an improved prognosis, as shown in the treatment guidelines from the American College of Rheumatology (ACR)1 and the European Alliance of Associations for Rheumatology (EULAR).However, in low-income and middle-income countries, such as those in Latin America, it is necessary to establish the applicability of these guidelines given the low availability or excessive costs of some drugs. Therefore, guidelines adapted to the unmet needs of Latin America are necessary. We read with great interest the recently published Pan American League of Associations for Rheumatology (PANLAR) guidelines by Sebastián J Magri and colleagues, which included 21 recommendations on induction and remission strategies...